Genetic alteration in melanoma development

Pjanova, Dace; Azarjana, Kristīne; Čēma, Ingrīda; Heisele, Olita

doi:10.2478/v10046-009-0029-2

Abstract

The transition from a normal to a neoplastic cell is a complex process and involves many sequential genetic events. Over the last several years, substantial progress has been made in the understanding of molecular biology of melanoma including its development, progression, and resistance to therapy. An important step in cancer development appears to be senescence — a crucial barrier that prevents the proliferation of cells that are at different stages of malignancy. This review is mainly focused on patterns of molecular changes in the different steps of neoplastic transformation in melanoma and provides an up-to-date view on our understanding of the molecular genetics of melanoma development as well as therapeutic approaches based on this knowledge.

References

Balch, C.M., Buzaid, A.C., Soong, S.J., Atkins, M.B., Cascinelli, N., Coit, D.G., Fleming, I.D., Gershenwald, J.E., Houghton, A., Jr., Kirkwood, J.M., McMasters, K.M., Mihm, M.F., Morton, D.L., Reintgen, D.S., Ross, M.I., Sober, A., Thompson, J.A., Thompson. J.F. (2001). Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol., 19(16), 3635-3648.10.1200/JCO.2001.19.16.3635
Search in Google Scholar
Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., Sampas, N., Dougherty, E., Wang, E., Marincola, F., Gooden, C., Lueders, J., Glatfelter, A., Pollock, P., Carpten, J., Gillanders, E., Leja, D., Dietrich, K., Beaudry, C., Berens, M., Alberts, D., Sondak, V. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 406(6795), 536-540.
Search in Google Scholar
Blackwood, M. A., Holmes, R., Synnestvedt, M., Young, M., George, C., Yang, H., Elder D. E., Schuchter, L. M., Guerry, D., Ganguly, A. (2002). Multiple primary melanoma revisited. Cancer., 94(8), 2248-2255.10.1002/cncr.10454
Search in Google Scholar
Byrd, K.M., Wilson, D.C., Hoyler, S.S., Peck, G.L. (2004). Advanced presentation of melanoma in African Americans. J. Amer. Acad. Dermatol., 50(1), 142-143.10.1016/S0190-9622(03)02091-7
Search in Google Scholar
Clark, W.H. Jr., Elder, D.E., Guerry, D. 4^th, Epstein, M.N., Greene, M.H., Van Horn, M. (1984). A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol., 15(12), 1147-1165.10.1016/S0046-8177(84)80310-X
Search in Google Scholar
Curtin, J.A., Fridlyand, J., Kageshita, T., Patel, H.N., Busam, K.J., Kutzner, H., Cho, K.H., Aiba, S., Brocker, E.B., LeBoit, P.E., Pinkel, D., Bastian, B.C. (2005). Distinct sets of genetic alterations in melanoma. New Engl. J. Med., 353(20), 2135-2147.10.1056/NEJMoa05009216291983
Search in Google Scholar
Danen, E.H., Ten Berge, P.J., Van Muijen, G.N., Van't Hof-Grootenboer, A.E., Brocker, E.B., Ruiter, D.J. (1994). Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology, 24(3), 249-256.10.1111/j.1365-2559.1994.tb00517.x7515372
Search in Google Scholar
Daniotti, M., Oggionni, M., Ranzani, T., Vallacchi, V., Campi, V., Di Stasi, D., Torre, G.D., Perrone, F., Luoni, C., Suardi, S., Frattini, M., Pilotti, S., Anichini, A., Tragni, G., Parmiani, G., Pierotti, M.A., Rodolfo, M. (2004). BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene, 23(35), 5968-5977.10.1038/sj.onc.120778015195137
Search in Google Scholar
Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B.A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G.J., Bigner, D.D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J.W., Leung, S.Y., Yuen, S.T., Weber, B.L., Seigler, H.F., Darrow, T.L., Paterson, H., Marais, R., Marshall, C.J., Wooster, R., Stratton, M.R., Futreal, P.A. (2002). Mutations of the BRAF gene in human cancer. Nature, 417(6892), 949-954.
Search in Google Scholar
de Snoo, F.A., Hayward, N.K. (2005). Cutaneous melanoma susceptibility and progression genes. Cancer Lett., 230(2), 153-186.10.1016/j.canlet.2004.12.03316297704
Search in Google Scholar
Demunter, A., Stas, M., Degreef, H., De Wolf-Peeters, C., van den Oord, J.J. (2001). Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J. Invest. Dermatol., 117(6), 1483-1489.10.1046/j.0022-202x.2001.01601.x11886512
Search in Google Scholar
Dhawan, P., Singh, A.B., Ellis, D.L., Richmond, A. (2002). Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res., 62(24), 7335-7342.
Search in Google Scholar
Diepgen, T.L., Mahler, V. (2002). The epidemiology of skin cancer. Brit. J. Dermatol., 146 (Suppl. 61), 1-6.10.1046/j.1365-2133.146.s61.2.x11966724
Search in Google Scholar
Du, J., Miller, A.J., Widlund, H.R., Horstmann, M.A., Ramaswamy, S., Fisher, D.E. (2003). MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Amer. J. Pathol., 163(1), 333-343.10.1016/S0002-9440(10)63657-7
Search in Google Scholar
Duncan, L.M., Deeds, J., Cronin, F.E., Donovan, M., Sober, A.J., Kauffman, M., McCarthy, J.J. (2001). Melastatin expression and prognosis in cutaneous malignant melanoma. J. Clin. Oncol., 19(2), 568-576.10.1200/JCO.2001.19.2.568
Search in Google Scholar
Edwards, R.H., Ward, M.R., Wu, H., Medina, C.A., Brose, M.S., Volpe, P., Nussen-Lee, S., Haupt, H.M., Martin, A.M., Herlyn, M., Lessin, S.R., Weber, B.L. (2004). Absence of BRAF mutations in UV-protected mucosal melanomas. J. Med. Genet., 41(4), 270-272.10.1136/jmg.2003.016667
Search in Google Scholar
Felding-Habermann, B., Fransvea, E., O'Toole, T.E., Manzuk, L., Faha, B., Hensler, M. (2002). Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis, 19(5), 427-436.10.1023/A:1016377114119
Search in Google Scholar
Garbe, C., McLeod, G.R., Buettner, P.G. (2000). Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer, 89, 1269-1278.10.1002/1097-0142(20000915)89:6<;1269::AID-CNCR11>3.0.CO;2-C
Search in Google Scholar
Garraway, L.A., Widlund, H.R., Rubin, M.A., Getz, G., Berger, A.J., Ramaswamy, S., Beroukhim, R., Milner, D.A., Granter, S.R., Du, J., Lee, C., Wagner, S.N., Li, C., Golub, T.R., Rimm, D.L., Meyerson, M.L., Fisher, D.E., Sellers, W.R. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature, 436(7047), 117-122.
Search in Google Scholar
Goldstein, A.M., Chan, M., Harland, M., Hayward, N.K., Demenais, F., Timothy Bishop, D., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., Calista, D., Cannon Albright, L.A., Chaudru, V., Chompret, A., Cuellar, F., Elder, D.E., Ghiorzo, P., Gillanders, E.M., Gruis, N.A., Hansson, J., Hogg, D., Holland, E.A., Kanetsky, P.A., Kefford, R.F., Teresa Landi, M., Lang, J., Leachman, S.A., Mackie, R.M., Magnusson, V., Mann, G.J., Newton Bishop, J., Palmer, J.M., Puig, S., Puig-Butille, J.A., Stark, M., Tsao, H., Tucker, M.A., Whitaker, L., Yakobson, E. (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J. Med. Genet., 44(2), 99-106.10.1136/jmg.2006.043802
Search in Google Scholar
Gorden, A., Osman, I., Gai, W., He, D., Huang, W., Davidson, A., Houghton, A.N., Busam, K., Polsky, D. (2003). Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res., 63(14), 3955-3957.
Search in Google Scholar
Gray-Schopfer, V.C., Cheong, S.C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z.A., Marais, R., Wynford-Thomas, D., Bennett, D.C. (2006). Cellular senescence in naevi and immortalisation in melanoma: A role for p16? Br. J. Cancer, 95(4), 496-505.10.1038/sj.bjc.6603283
Search in Google Scholar
Hammock, L., Cohen, C., Carlson, G., Murray, D., Ross, J.S., Sheehan, C., Nazir, T.M., Carlson, J.A. (2006). Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma. J. Cutan. Pathol., 33(9), 599-607.10.1111/j.1600-0560.2006.00501.x
Search in Google Scholar
Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B.L., Federman, S., Miller, J.R. 3^rd, Allen, R.E., Singer, M.I., Leong, S.P., Ljung, B.M., Sagebiel, R.W., Kashani-Sabet, M. (2005). The gene expression signatures of melanoma progression. Proc. Natl. Acad. Sci. USA, 102(17), 6092-6097.10.1073/pnas.0501564102
Search in Google Scholar
Hofmann, U.B., Westphal, J.R., Waas, E.T., Becker, J.C., Ruiter, D.J., van Muijen, G.N. (2000) Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. J. Invest. Dermatol., 115(4), 625-632.10.1046/j.1523-1747.2000.00114.x
Search in Google Scholar
Hornberg, J.J., Bruggeman, F.J., Westerhoff, H.V., Lankelma, J. (2006). Cancer: A Systems Biology disease. Biosystems, 83(2-3), 81-90.10.1016/j.biosystems.2005.05.014
Search in Google Scholar
Hsu, M.Y., Meier, F.E., Nesbit, M., Hsu, J.Y., Van Belle, P., Elder, D.E., Herlyn, M. (2000a). E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Amer. J. Pathol., 156(5), 1515-1525.10.1016/S0002-9440(10)65023-7
Search in Google Scholar
Hsu, M., Andl, T., Li, G., Meinkoth, J.L., Herlyn, M. (2000b). Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J. Cell Sci., 113 (Pt 9), 1535-1542.10.1242/jcs.113.9.1535
Search in Google Scholar
Jiveskog, S., Ragnarsson-Olding, B., Platz, A., Ringborg, U. (1998). N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J. Invest. Dermatol., 111(5), 757-761.10.1046/j.1523-1747.1998.00376.x
Search in Google Scholar
Kumar, R., Angelini, S., Snellman, E., Hemminki, K. (2004). BRAF mutations are common somatic events in melanocytic nevi. J. Invest. Dermatol., 122(2), 342-348.10.1046/j.0022-202X.2004.22225.x
Search in Google Scholar
Li, X., Regezi, J., Ross, F.P., Blystone, S., Ilic, D., Leong, S.P., Ramos, D.M. (2001). Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro. J. Cell Sci., 114(Pt 14), 2665-2672.10.1242/jcs.114.14.2665
Search in Google Scholar
Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., Eng, C., Parsons, R. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16(1), 64-67.10.1038/ng0597-64
Search in Google Scholar
Miller, A.J., Mihm, M.C. Jr. (2006). Melanoma. New Engl. J. Med., 355(1), 51-65.10.1056/NEJMra052166
Search in Google Scholar
Ortega, S., Malumbres, M., Barbacid, M. (2002). Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta, 1602(1), 73-87.10.1016/S0304-419X(02)00037-9
Search in Google Scholar
Papp, T., Pemsel, H., Zimmermann, R., Bastrop, R., Weiss, D.G., Schiffmann, D. (1999). Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet., 36(8), 610-614.
Search in Google Scholar
Petitelerc, E., Stromblad, S., von Schalscha, T.L., Mitjans, F., Piulats, J., Montgomery, A.M., Cheresh, D.A., Brooks, P.C. (1999). Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res., 59(11), 2724-2730.
Search in Google Scholar
Pollock, P.M., Harper, U.L., Hansen, K.S., Yudt, L.M., Stark, M., Robbins, C.M., Moses, T.Y., Hostetter, G., Wagner, U., Kakareka, J., Salem, G., Pohida, T., Heenan, P., Duray, P., Kallioniemi, O., Hayward, N.K., Trent, J.M., Meltzer, P.S. (2003). High frequency of BRAF mutations in nevi. Nat. Genet., 33(1), 19-20.10.1038/ng105412447372
Search in Google Scholar
Poynter, J.N., Elder, J.T., Fullen, D.R., Nair, R.P., Soengas, M.S., Johnson, T.M., Redman, B., Thomas, N.E., Gruber, S.B. (2006). BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res., 16(4), 267-273.10.1097/01.cmr.0000222600.73179.f316845322
Search in Google Scholar
Reifenberger, J., Knobbe, C.B., Sterzinger, A.A., Blaschke, B., Schulte, K.W., Ruzicka, T., Reifenberger, G. (2004). Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Int. J. Cancer, 109(3), 377-384.10.1002/ijc.1172214961576
Search in Google Scholar
Rhodes, A.R., Weinstock, M.A., Fitzpatrick, T.B., et al. (1987). Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA, 258(21), 3146-3154.10.1001/jama.1987.03400210088032
Search in Google Scholar
Rodolfo, M., Daniotti, M., Vallacchi, V. (2004). Genetic progression of metastatic melanoma. Cancer Lett., 214(2), 133-147.10.1016/j.canlet.2004.06.04915363539
Search in Google Scholar
Rusciano, D. (2000). Differentiation and metastasis in melanoma. Crit. Rev. Oncog., 11(2), 147-163.
Search in Google Scholar
Saldanha, G., Purnell, D., Fletcher, A., Potter, L., Gillies, A., Pringle, J.H. (2004). High BRAF mutation frequency does not characterize all melanocytic tumor types. Int. J. Cancer, 111(5), 705-710.10.1002/ijc.2032515252839
Search in Google Scholar
Sasaki, Y., Niu, C., Makino, R., Kudo, C., Sun, C., Watanabe, H., Matsunaga, J., Takahashi, K., Tagami, H., Aiba, S., Horii, A. (2004). BRAF point mutations in primary melanoma show different prevalences by subtype. J. Invest. Dermatol., 123(1), 177-183.10.1111/j.0022-202X.2004.22722.x15191558
Search in Google Scholar
Sharpless, N.E., DePinho, R.A. (2005). Cancer: Crime and punishment. Nature, 436(7051), 636-637.
Search in Google Scholar
Stahl, J.M., Sharma, A., Cheung, M., Zimmerman, M., Cheng, J.Q., Bosenberg, M.W., Kester, M., Sandirasegarane, L., Robertson, G.P. (2004). Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res., 64(19), 7002-7010.10.1158/0008-5472.CAN-04-139915466193
Search in Google Scholar
Takeuchi, H., Kuo, C., Morton, D.L., Wang, H.J., Hoon, D.S. (2003). Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas. Cancer Res., 63(2), 441-448.
Search in Google Scholar
Thomas, N.E., Alexander, A., Edmiston, S.N., Parrish, E., Millikan, R.C., Berwick, M., Groben, P., Ollila, D.W., Mattingly, D., Conway, K. (2004). Tandem BRAF mutations in primary invasive melanomas. J. Invest. Dermatol., 122(5), 1245-1250.10.1111/j.0022-202X.2004.22523.x15140228
Search in Google Scholar
Tsao, H., Goel, V., Wu, H., Yang, G., Haluska, F.G. (2004). Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J. Invest. Dermatol., 122(2), 337-341.10.1046/j.0022-202X.2004.22243.x258666815009714
Search in Google Scholar
Tsao, H., Zhang, X., Fowlkes, K., Haluska, F.G. (2000). Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res., 60(7), 1800-1804.
Search in Google Scholar
Uribe, P., Wistuba, I.I., Gonzalez, S. (2003). BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Amer. J. Dermatopathol., 25(5), 365-670.10.1097/00000372-200310000-0000114501284
Search in Google Scholar
van Elsas, A., Zerp, S.F., van der Flier, S., Kruse, K.M., Aarnoudse, C., Hayward, N.K., Ruiter, D.J., Schrier, P.I. (1996). Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Amer. J. Pathol., 149(3), 883-893.
Search in Google Scholar
Williams, M.L., Sagebiel, R.W. (1994). Melanoma risk factors and atypical moles. West. J. Med., 160(4), 343-350.
Search in Google Scholar
Wu, H., Goel, V., Haluska, F.G. (2003). PTEN signaling pathways in melanoma. Oncogene, 22(20), 3113-3122.10.1038/sj.onc.1206451
Search in Google Scholar
Yazdi, A.S., Palmedo, G., Flaig, M.J., Puchta, U., Reckwerth, A., Rutten, A., Mentzel, T., Hugel, H., Hantschke, M., Schmid-Wendtner, M.H., Kutzner, H., Sander, C.A. (2003). Mutations of the BRAF gene in benign and malignant melanocytic lesions. J. Invest. Dermatol., 121(5), 1160-1162.10.1046/j.1523-1747.2003.12559.x
Search in Google Scholar
Zhang, Y., Xiong, Y., Yarbrough, W.G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92(6), 725-734.10.1016/S0092-8674(00)81401-4
Search in Google Scholar

Genetic alteration in melanoma development

Abstract

Paradigm

My account